Skip to main content

ANALISIS ESTRUCTURAL Y FUNCIONAL DE LA RED DE INTERACCIONES DEL CITOCROMO C EN LA COMUNICACION MITOCONDRIA-NUCLEO

PID2021-126663NB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

DATASET A splice-altering homozygous variant in COX18 causes severe sensory-motor neuropathy with oculofacial apraxia

  • Mavillard, Fabiola
  • Guerra-Castellano, Alejandra
  • Rívas, Eloy
  • Cantero, Gloria
  • Servián Morilla, E.
  • Folland, Chiara
  • Ravenscroft, Gianina
  • Martín, Miguel A.
  • Cabrera-Serrano, Macarena
  • Díaz-Moreno, Irene
  • Paradas-López, Carmen
Cytochrome-c oxidase (COX) is part of the mitochondrial complex IV (CIV). COX deficiency is usually associated with tRNA variants, and less frequently with variants in COX assembly factors. Mutations in COX subunits encoded by mitochondrial DNA and nuclear DNA are rare, likely because most of them are associated to very severe phenotypes with early lethality. COX18, an assembly factor of CIV, has long been analyzed as a potential cause of mitochondrial disease. To date, only one patient has been identified carrying a homozygous missense variant in COX18, associated with neonatal encephalo-cardiomyopathy and axonal sensory neuropathy. Here, we describe a 40-year-old patient, asymptomatic until 7 months of age, who presented with progressive muscle weakness resembling spinal muscle atrophy type-2, associated with oculofacial apraxia and dysarthric speech. Electrophysiology analysis highlighted a severe sensory-motor neuropathy. Muscle biopsy showed striking and diffuse decreases of COX staining and a substantial reduction of CIV activity. Muscle biopsy showed no ragged-red fibers, although ultrastructural mitochondrial alterations were evident. A novel homozygous variant (c.598G>A), located in the last nucleotide of exon 3, was detected in COX18 by whole-exome sequencing, which affected the splicing donor site, as demonstrated by cDNA-seq. The patient fibroblasts express a truncated form of COX18 (COX18Δ112-240) capable of assembling CIV and CIV-involving supercomplexes. However, CIV activity was decreased. COX18 full-length (COX18-fl) overexpression partially rescued CIV activity in the patient fibroblasts. The rescue of the null CIV activity in COX18-KO-HEK293 cells by overexpressing of COX18Δ112-240 was significantly lower than in cells with COX18-fl. In addition, cox-18 downregulation in C. elegans resulted in slow growth and, diminished reduced motility phenotypes and as well as severe fragmentation of the mitochondrial network. Our case expands the phenotypes associated with COX18 variants and supports the pathogenic role of COX18 as the cause of a severe encephaloneuropathy syndrome, The authors acknowledge the patient and his family, as well as the patient association ASENSE for all the support to this work. We also acknowledge the facilities and scientific and technical assistance of CITIUS (University of Seville) and the Biomolecular Mass Spectrometry Service of the Pablo de Olavide University. This work was supported in part by the Instituto de Salud Carlos III (FIS PI19-01497 to C. Paradas), Consejería de Salud y Familia, Junta de Andalucía and Programa Operativo Fondo Social Europeo de Andalucía 2014–2020 (RH0046-2020 to G.C) and Consejería de Salud y Consumo, Junta de Andalucía and Programa Nicolas Monarde (C1-0003-2022 to E.S-M). We also acknowledge the FP7 WeNMR (project# 261572), H2020 West-Life (project# 675858), the EOSC-hub (project# 777536) and the EGI-ACE (project# 101017567) European e-Infrastructure projects for the use of their web portals, which make use of the EGI infrastructure with the dedicated support of CESNET-MCC, INFN-LNL-2, NCG-INGRID-PT, TW-NCHC, CESGA, IFCA-LCG2, UA-BITP, TR-FC1-ULAKBIM, CSTCLOUD-EGI, IN2P3-CPPM, CIRMMP, SURFsara and NIKHEF, and the additional support of the national GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, UK, Taiwan and the US Open Science Grid. This work was supported by the Spanish Government (PGC2018-096049-B-I00, FEDER/Ministerio de Ciencia e Innovación — Agencia Estatal de Investigación Grant PID2021-126663NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe), European Regional Development Fund (FEDER), Andalusian Government (BIO-198, US/JUNTA/FEDER) and the Ramón Areces Foundation (2021–2024 to I.D.-M.). Some of the authors are part of the European Research Network in Neuromuscular Diseases (EURO-NMD)., Peer reviewed